Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Commentary

COVID-19 Realization: The Critical Need for Pharmacists in Health Care and Relationship to Provider Status
Commentary
COVID-19 Realization: The Critical Need for Pharmacists in Health Care and Relationship to Provider Status
04/27/2020
Mark Munger, PharmD, explains why pharmacists have the ability to provide important health care services during this time, but cautions if pharmacists have the proper training to assume roles in an unfamiliar landscape.
Mark Munger, PharmD, explains why pharmacists have the ability to provide important health care services during this time, but cautions if pharmacists have the proper training to assume roles in an unfamiliar landscape.
Mark Munger, PharmD, explains...
04/27/2020
Pharmacy Learning Network
Hydroxychloroquine for COVID-19: Have We Forgotten Something?
Commentary
Hydroxychloroquine for COVID-19: Have We Forgotten Something?
04/21/2020
“So how can we safely and effectively dose hydroxychloroquine in COVID-19? The answer is we can’t and unfortunately this outcome is being played out in human trials around the world,” says Mark Munger, PharmD.
“So how can we safely and effectively dose hydroxychloroquine in COVID-19? The answer is we can’t and unfortunately this outcome is being played out in human trials around the world,” says Mark Munger, PharmD.
“So how can we safely and...
04/21/2020
Pharmacy Learning Network

Advertisement

Antiviral Therapy for SARS-CoV-2: Fact or Fiction—Opinion
Commentary
Antiviral Therapy for SARS-CoV-2: Fact or Fiction—Opinion
04/17/2020
Douglas Jennings, PharmD, takes a deeper look at promising antiviral agents with potential futures as treatment modalities for this ever-evolving global pandemic.
Douglas Jennings, PharmD, takes a deeper look at promising antiviral agents with potential futures as treatment modalities for this ever-evolving global pandemic.
Douglas Jennings, PharmD, takes...
04/17/2020
Pharmacy Learning Network
Commentary
Prescribing Errors Associated With Use of Oxytocin and Strategies to Mitigate Risk of Such Errors: Part I
04/09/2020
Neha Kumar, PharmD, discusses how improper administration of oxytocin can impact patients, and provides tips that support the correct selection and appropriate use of medications.
Neha Kumar, PharmD, discusses how improper administration of oxytocin can impact patients, and provides tips that support the correct selection and appropriate use of medications.
Neha Kumar, PharmD, discusses...
04/09/2020
Pharmacy Learning Network
Fact or Fiction: Exploring Treatments for COVID-19—Opinion
Commentary
Fact or Fiction: Exploring Treatments for COVID-19—Opinion
04/08/2020
Douglas Jennings, PharmD, examines potential therapy options that have emerged since the pandemic, and highlights where the data may support use for SARS-CoV-2.
Douglas Jennings, PharmD, examines potential therapy options that have emerged since the pandemic, and highlights where the data may support use for SARS-CoV-2.
Douglas Jennings, PharmD,...
04/08/2020
Pharmacy Learning Network

Advertisement

Shortages Beyond PPE
Commentary
Shortages Beyond PPE
04/07/2020
According to Douglas Jennings, PharmD, “stockpiles of key medications needed to care for patients infected with SARS CoV 2 are dwindling, forcing many hospitals to ration remaining supplies and scramble to procure alternative therapies.”
According to Douglas Jennings, PharmD, “stockpiles of key medications needed to care for patients infected with SARS CoV 2 are dwindling, forcing many hospitals to ration remaining supplies and scramble to procure alternative therapies.”
According to Douglas Jennings,...
04/07/2020
Pharmacy Learning Network
Drug Therapy for Coronavirus: Misinformation and Concern for Our Local Pharmacies
Commentary
Drug Therapy for Coronavirus: Misinformation and Concern for Our Local Pharmacies
04/03/2020
Michael Cawley, PharmD, explains why he has concerns regarding the spread of false or misleading information that may put pharmacy staff in danger of theft and robbery due to mass chaos of hearing about “promising” drugs.
Michael Cawley, PharmD, explains why he has concerns regarding the spread of false or misleading information that may put pharmacy staff in danger of theft and robbery due to mass chaos of hearing about “promising” drugs.
Michael Cawley, PharmD, explains...
04/03/2020
Pharmacy Learning Network
COVID and the Cardiovascular System
Commentary
COVID and the Cardiovascular System
04/01/2020
Douglas Jennings, PharmD, discusses how COVID-19 interacts with the cardiovascular system, including increasing morbidity in patients with underlying cardiovascular conditions, and provoking myocardial injury.
Douglas Jennings, PharmD, discusses how COVID-19 interacts with the cardiovascular system, including increasing morbidity in patients with underlying cardiovascular conditions, and provoking myocardial injury.
Douglas Jennings, PharmD,...
04/01/2020
Pharmacy Learning Network

Advertisement

Remain Positive, Stay Mentally and Physically Active, and Plan for Changes in How We Conduct our Practices
Commentary
Remain Positive, Stay Mentally and Physically Active, and Plan for Changes in How We Conduct our Practices
04/01/2020
Mark Munger, PharmD, provides several tips to strengthen our fortitude moving forward during these times.
Mark Munger, PharmD, provides several tips to strengthen our fortitude moving forward during these times.
Mark Munger, PharmD, provides...
04/01/2020
Pharmacy Learning Network
Strategy to Bring a Free Market System to the United States Health Care System
Commentary
Strategy to Bring a Free Market System to the United States Health Care System
03/27/2020
Mark Munger, PharmD, discusses if an alternative economic health care plan, based on free market principles, can be created.
Mark Munger, PharmD, discusses if an alternative economic health care plan, based on free market principles, can be created.
Mark Munger, PharmD, discusses...
03/27/2020
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use